English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset.

MPS-Authors
/persons/resource/persons45923

Ryazanov,  S.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15438

Leonov,  A.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15147

Griesinger,  C.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

Fulltext (public)

2029603.pdf
(Publisher version), 189KB

Supplementary Material (public)
There is no public supplementary material available
Citation

Levin, J., Schmidt, F., Boehm, C., Prix, C., Bötzel, K., Ryazanov, S., et al. (2014). The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset. Acta Neuropathologica, 127(5), 779-780. doi:10.1007/s00401-014-1265-3.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0019-8C7F-0
Abstract
There is no abstract available